首页> 美国卫生研究院文献>The Journal of Physiology >Apparent Ca2+ dissociation constant of Ca2+ chelators incorporated non-disruptively into intact human red cells.
【2h】

Apparent Ca2+ dissociation constant of Ca2+ chelators incorporated non-disruptively into intact human red cells.

机译:Ca2 +螯合剂的表观Ca2 +解离常数无干扰地整合到完整的人类红细胞中。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

1. A recently developed method of measuring cytoplasmic Ca2+ buffering in intact red cells was applied to re-evaluate the intracellular Ca2+ binding properties of the Ca2+ chelators benz2 and BAPTA. Incorporation of the free chelators was accomplished by incubating the cells with the acetoxymethyl ester forms (benz2 AM or BAPTA AM). The divalent cation ionophore A23187 was used to induce equilibrium distribution of Ca2+ between cells and medium. 45Ca2+ was added stepwise to cell suspensions in the presence and absence of external BAPTA. To induce full Ca2+ equilibration, the plasma membrane Ca2+ pump was inhibited either by depleting the cells of ATP or by adding vanadate to the cell suspension. 2. The properties of the incorporated chelators were assessed from the difference in cytoplasmic Ca2+ buffering between chelator-free and chelator-loaded cells, over a wide range of intracellular ionized calcium concentrations ([Ca2+]i), from nanomolar to millimolar. 3. Under the experimental conditions applied, incorporation of benz2 and BAPTA into the red cells increased their Ca2+ buffering capacity by 300-600 mumol (340 g Hb)-1. The intracellular apparent Ca2+ dissociation constants (KDi) were about 500 nM for benz2 and 800 nM for BAPTA, values much higher than those reported for standard salt solutions (KD) of about 40 and 130 nM, respectively. These results suggest that, contrary to earlier observations, the intracellular red cell environment may cause large shifts in the apparent Ca2+ binding behaviour of incorporated chelators. 4. The possibility that the observed KD shifts are due to reversible binding of the chelators to haemoglobin is considered, and the implications of the present results for early estimates of physiological [Ca2+]i levels is discussed.
机译:1.一种新近开发的测量完整红细胞中细胞质Ca2 +缓冲的方法被用于重新评估Ca2 +螯合剂benz2和BAPTA的细胞内Ca2 +结合特性。通过将细胞与乙酰氧基甲基酯形式(benz2 AM或BAPTA AM)一起孵育来完成游离螯合剂的掺入。使用二价阳离子离子载体A23187诱导细胞和培养基之间Ca2 +的平衡分布。在存在和不存在外部BAPTA的情况下,将45Ca2 +逐步添加到细胞悬液中。为了诱导完全的Ca2 +平衡,通过消耗ATP细胞或向细胞悬液中添加钒酸盐来抑制质膜Ca2 +泵。 2.结合的螯合剂的性质是通过在从纳摩尔到毫摩尔的多种细胞内电离钙浓度([Ca2 +] i)范围内,从无螯合剂和负载有螯合剂的细胞之间的胞质Ca2 +缓冲作用的差异来评估的。 3.在所应用的实验条件下,将benz2和BAPTA掺入红细胞中可使其Ca2 +缓冲能力增加300-600 mumol(340 g Hb)-1。细胞内表观Ca2 +解离常数(KDi)对于benz2为约500 nM,对于BAPTA为800 nM,其值分别比标准盐溶液(KD)分别约40和130 nM的值高得多。这些结果表明,与早期观察相反,细胞内红细胞环境可能导致掺入的螯合剂的表观Ca2 +结合行为发生重大变化。 4.考虑到观察到的KD位移是由于螯合剂与血红蛋白的可逆结合所引起的可能性,并讨论了当前结果对生理[Ca2 +] i水平的早期估计的意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号